Cas medical systems inc (CASM)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Net sales from continuing operations

21,919

18,763

-

-

-

-

-

-

-

Net sales from continuing operations

-

-

18,674

19,486

19,214

21,915

22,669

22,450

24,086

Cost of sales

-

-

8,175

9,516

10,656

13,958

13,565

-

-

Asset impairment charge

-

-

-

-

-

407

-

-

-

Cost of sales

9,213

8,505

-

-

-

14,365

13,565

13,892

14,128

Gross profit

12,706

10,258

10,498

9,970

8,558

7,550

9,103

8,557

9,957

Operating expenses:
Research and development

3,181

3,234

3,272

3,514

3,316

4,211

4,019

3,525

1,689

Selling, general and administrative

14,015

13,418

13,569

13,097

11,956

13,792

12,528

11,509

9,956

Total operating expenses

17,197

16,652

16,842

16,611

15,273

18,003

16,548

15,034

11,645

Operating loss

-4,491

-6,394

-6,343

-6,641

-6,714

-10,453

-7,444

-6,476

-1,687

Interest expense, net

1,469

1,076

1,048

859

786

316

113

-

-

Other income

-

-

42

4

18

407

39

26

-59

Loss from continuing operations before income taxes

-5,961

-7,470

-7,349

-7,496

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-7,519

-6,450

-1,747

Income tax benefit

-

-1,745

-1,424

-209

-

-

-211

-124

-147

Loss from continuing operations

-5,961

-5,725

-5,925

-7,287

-7,483

-

-

-6,325

-1,599

Discontinued operations:
Income from discontinued operations

-

745

1,277

621

-

-

-

-

-

Gain on sale of discontinued operations

-

4,388

2,911

-24

-

-

-

-

-

Income tax expense

-

1,745

1,424

209

-

-

-

-

-

Income from discontinued operations

-

3,388

2,764

388

-

-

-

242

294

Loss from discontinued operations

-

-

-

-

-117

-

-

-

-

Net loss

-5,961

-2,337

-3,161

-6,898

-7,601

-10,362

-7,308

-6,083

-1,305

Preferred stock dividend accretion

1,703

1,589

1,482

1,383

1,290

1,203

1,123

631

-

Net loss applicable to common stockholders

-7,664

-3,926

-4,643

-8,281

-8,892

-11,566

-8,431

-6,714

-

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-1,305

Loss per common share from continuing operations - basic and diluted

-0.28

-0.27

-0.28

-0.34

-0.46

-

-

-0.53

-0.13

Income per common share from discontinued operations: basic and diluted

-

0.13

0.11

0.02

0.00

-

-

0.02

0.02

Per share basic and diluted loss applicable to common stockholders

-0.28

-0.14

-0.17

-0.32

-0.46

-0.73

-0.63

-0.51

-0.11

Weighted-average number of common shares outstanding: Basic and diluted

27,769

27,260

26,826

25,700

19,235

15,771

13,286

13,104

12,175